Swiss stocks - Factors to watch on August 4

Crispr Therapeutics AG

04/08/2026 05:53

ZURICH/GDANSK, Aug 4(Reuters) - Here are some of the main factors that may affect Swiss stocks on Tuesday:
     
UBS GROUP AG UBSG.S 
The company was fined $125 million by U.S. regulators on Monday for violating the Bank Secrecy Act, the largest civil fine ever against a broker-dealer for violating the main U.S. anti-money laundering law.

CRISPR THERAPEUTICS AG CRSP.BN 
Switzerland-U.S. gene-editing firm's Q2 CASGEVY revenue rose 151% yr/yr to $76 million.


ANALYSTS' VIEWS
No rating changes.
       
ECONOMY
No major Swiss economic data scheduled.
   


 (Reporting by Zurich newsroom and Gdansk newsroom)
 ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g

FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES

Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH  
All equity news E

SPEED GUIDES:  EQUITY, EQUITY/NEWS1, EUR/EQUITY, SWITZERLAND, REUTERS